Decision on emergency use listing of Covaxin likely in 4-6 weeks: WHO

According to WHO guidelines, EUL is a procedure to streamline the process by which new or unlicensed products can be used during public health emergencies.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3yJdghf
via IFTTT